Ligand validation:4RDR

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 4RDR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RDR_C8E_A_804	48%	53%	0.174	0.917	0.94	0.87	-	-	1	0	100%	1
4RDR_C8E_A_806	24%	57%	0.233	0.863	0.86	0.81	-	-	5	0	100%	1
4RDR_C8E_A_805	19%	56%	0.248	0.843	0.8	0.9	-	-	0	0	100%	1
4RDR_C8E_A_808	19%	57%	0.254	0.846	0.78	0.86	-	-	7	0	100%	1
4RDR_C8E_A_807	10%	62%	0.278	0.787	0.67	0.79	-	-	1	0	100%	1
4RDT_C8E_A_805	44%	81%	0.143	0.869	0.32	0.5	-	-	1	0	100%	1
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
8XWO_C8E_A_402	94%	77%	0.046	0.989	0.45	0.46	-	-	2	0	76%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	4	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.